CLINICAL_TRIALS
trial_result
· 2026-01-14
Clinical Trial Update: Hypofractionated Radiation Therapy for Merkel Cell Carcinoma [Phase 2]
Summary
Phase 2 clinical trial update notes recruitment for hypofractionated radiation therapy in Merkel cell carcinoma; the study is currently enrolling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Merkel Cell Carcinoma | Phase 2 | Status: RECRUITING